Jennifer Damico is Vice President, Corporate Audit, Pfizer Inc, reporting to the Audit Committee of the Board of Directors and the Chief Financial Officer. She is responsible for leading 100 audit professionals primarily based in New York, New Jersey, Connecticut, Pennsylvania, Mumbai, Dublin and Beijing. Corporate Audit provides independent, Pan-Pfizer corporate regulatory audit and oversight of processes and systems spanning the company's operating model including: discovery, development, manufacturing, commercial sales & marketing activities, finance and information technology.

Jennifer joined Pfizer in 1992 and has held positions of increasing responsibility in Audit, Information Technology, and Finance. She joined the company as a Senior Internal Auditor and was promoted to Audit Manager in 1994. In 1997, Jennifer joined the Corporate Information Technology Division as Director of Finance and Controller. In 2001, she rejoined Internal Audit as an Audit Director and was promoted to Senior Director, Strategy, Governance and Operations in 2008. Jennifer served as the Program Management Office (PMO) Lead for the Finance One transformation program and led the finance integration for the King acquisition. In 2010, she became Vice President, Finance Portfolio Management & Optimization, and established a new organization to provide centralized, customer-focused project & change management as well as coordination of finance integration and divestiture activities which more recently included supporting the Nutritional and Animal Health divestitures. Prior to joining Pfizer, she worked as a senior auditor for Arthur Andersen.

Jennifer holds a Master of Business Administration degree from Pace University and is a Certified Public Accountant. She is married with two children Ryan, 15 and Courtney, 13 and lives in Long Island, NY.